Espervita Therapeutics is a developer of metabolic reprogramming therapies used for the treatment of cancers. Its therapies focus on the areas with a significant unmet medical need such as the treatment for liver cancer amongst others to help medical professionals to have therapeutic expertise to prevent cancer cell proliferation, increase immune detection, and reduce tumor burden. The company was founded in 2018 and is headquartered in Saline, Michigan.

Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI.

Shengzhan Biotechnology Co., Ltd. was established in April of the Republic of China. It is an emerging important strategic industry. Its business is based on biotechnology, including microbial fermentation technology, research and development and production of APIs, health food ingredients, animal feed additives. And agricultural biotechnology products. The domestic stock listed company Shengda Chemical Pharmaceutical Co., Ltd. is the parent company of the company holding more than 50% of the shares. The company is a subsidiary of Shengda Company which is vertically integrated, aiming at developing high-tech and high value-added products. Reduce costs and benefit more people.

Avaliv Therapeutics is a drug discovery company focused on the development of novel small molecule therapeutics targeting inflammation and fibrosis related disorders. Our lead program is a first-in-class small molecule inhibitor for lysosomal proteases as a novel therapeutic intervention for non-alcoholic steatohepatitis (NASH) via an unexplored mechanistic pathway.

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

Jiangsu Province Hospital of Traditional Chinese Medicine is a Chinese private company located in Nanjing. The firm provides medical services.

Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Pharmaceuticals, Information Service, and Others. The Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism. The Information Service segment offers information services to use in IT and capital investment. The Others segment includes merchandise sales and construction contractors. The company was founded on August 9, 1946 and is headquartered in Matsumoto, Japan.

Jilin Northeast Asia Pharmaceutical Co., Ltd., established on 1999-02-09, Business range includes tablet,hard capsule,Granules,mixture,oral solution,pill(honey pill,honey pill),API(Total flavonoids from stems and leaves of Scutellaria baicalensis)Production;Manage the export business of the company's self-produced products and the machinery and equipment needed by the company,spare parts,Import and export business of raw and auxiliary materials,real estate lease,Chattel Lease;General cargo road transport,real estate sales,Chattel sales(Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangdong Tobacco Qingyuan Co., Ltd., established on 2001-09-18, Business scope includes cigarettes,Cigars purchased locally from across the country(city)wholesale;cut tobacco province(autonomous region,Municipality)buy local(city)wholesale;Tobacco Leaf Local(city)buy national sales;Confiscated cigarettes purchased locally(city)wholesale;imported cigarettes,cigars british province(autonomous region,Municipality)buy local(city)wholesale;tobacco planting;Purchase and sale of tobacco-specific pesticides,fertilizer,Agricultural film,Tobacco Packed Seeds;Operating project investment.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Arizona Board of Regents oversees college activities. The company was founded in 1864 and is headquartered in Phoenix, AZ.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Jiangxi Sinode New Materials Co., Ltd., established on 2020-07-14, Business scope includes general items:Magnetic Material Sales,Synthetic Materials Sales,R&D of metal products,New material technology promotion service(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

NeuroBo Pharmaceuticals is addressing unmet needs in patients with diabetic neuropathy and Alzheimer’s disease. Their Phase III-ready drug, NB-01, is based on natural sources and has shown successful Phase II results with excellent efficacy and safety in diabetic neuropathic pain (DNP) and they have strong preclinical data in both neuropathic pain and diabetes models showing a mode of action of NB-01 on nerve growth factor (NGF) release for nerve stabilization and regeneration. 40 to 50 percent of patients with diabetic peripheral neuropathy have some form of neuropathic pain and while existing drugs alleviate pain symptoms, they do not address the underlying disease. These current therapies also have a range of adverse effects, and only about 50 percent of patients respond positively. Additionally, the current therapies on the market were all initially approved for other disease states such as depression and fibromyalgia. NB-02, their lead Alzheimer’s drug, is in IND-enabling stage and has been extensively characterized in rodent models for mechanisms impacting Alzheimer’s disease (inhibition of AChE, pTau, amyloid-β, and stimulation of NGF for nerve growth. An aging population has resulted in an increase in the prevalence of Alzheimer’s disease, and the disease is a significant healthcare burden. Today, there are four approved drugs that manage the symptoms of Alzheimer’s disease, yet none of these four address disease modification.

Guangdong Dabeinong Aquatic Technology Co., Ltd., established on 2013-09-30, Business scope includes sales of livestock feed;Feed Additive Sales;Wholesale of edible agricultural products;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Feed Raw Material Sales;Bio-feed R&D;feed production;Veterinary drug business;Feed additive production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)